OOIR: Observatory of International Research

Papers

(The H4-Index of Respiratory Medicine is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Follow up of patients with severe coronavirus disease 2019 (COVID-19): Pulmonary and extrapulmonary disease sequelae	242
Pulmonary pathology of ARDS in COVID-19: A pathological review for clinicians	209
Pulmonary function and health-related quality of life after COVID-19 pneumonia	125
Levels of resilience, anxiety and depression in nurses working in respiratory clinical areas during the COVID pandemic	95
The role of oral microbiome in respiratory health and diseases	84
Smoking and COVID-19: What we know so far	82
Integrative respiratory follow-up of severe COVID-19 reveals common functional and lung imaging sequelae	81
Severity of respiratory failure and computed chest tomography in acute COVID-19 correlates with pulmonary function and respiratory symptoms after infection with SARS-CoV-2: An observational longitudin	72
COVID-19: Why does disease severity vary among individuals?	67
Clinical outcomes and quality of life of COVID-19 survivors: A follow-up of 3 months post hospital discharge	58
Idiopathic pulmonary hemosiderosis: A state of the art review	49
Pneumothorax in critically ill patients with COVID-19 infection: Incidence, clinical characteristics and outcomes in a case control multicenter study	49
Health-related quality of life profiles, trajectories, persistent symptoms and pulmonary function one year after ICU discharge in invasively ventilated COVID-19 patients, a prospective follow-up study	49
Colchicine and SARS-CoV-2: Management of the hyperinflammatory state	47
Candida spp. co-infection in COVID-19 patients with severe pneumonia: Prevalence study and associated risk factors	46
Respiratory rehabilitation for Covid-19 related persistent dyspnoea: A one-year experience	46
Managing malnutrition in COPD: A review	46
Risk factors and associated outcomes of hospital readmission in COPD: A systematic review	46
Tobacco use as a well-recognized cause of severe COVID-19 manifestations	45
Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity	43
Follow-up of functional exercise capacity in patients with COVID-19: It is improved by telerehabilitation	42
Residual ground glass opacities three months after Covid-19 pneumonia correlate to alteration of respiratory function: The post Covid M3 study	40
Complications after discharge with COVID-19 infection and risk factors associated with development of post-COVID pulmonary fibrosis	39
Mepolizumab effectiveness in patients with severe eosinophilic asthma and co-presence of bronchiectasis: A real-world retrospective pilot study	38
Poor outcome of SARS-CoV-2 infection in patients with severe asthma on biologic therapy	38

The effectiveness of pulmonary rehabilitation for Post-COVID symptoms: A rapid review of the literature	37
Survival in COPD patients treated with bronchoscopic lung volume reduction	37
Investigating the aggressiveness of the COVID-19 Omicron variant and suggestions for possible treatment options	36
Impaired diffusing capacity for carbon monoxide is common in critically ill Covid-19 patients at four months post-discharge	35
Galectin-3 as prognostic biomarker in patients with COVID-19 acute respiratory failure	34
Smoking and risk of COVID-19 hospitalization	34
Guidance on nebulization during the current COVID-19 pandemic	34
Clinical status and lung function 10 weeks after severe SARS-CoV-2 infection	34
Aquaporins in lung health and disease: Emerging roles, regulation, and clinical implications	34
Lung ultrasonography for long-term follow-up of COVID-19 survivors compared to chest CT scan	34